Gut Microbiota Modulates EHMT2 to Fight Kidney Cancer

Subject of Research: Cancer

Article Title: Gut Microbiota Modulates EHMT2 to Fight Kidney Cancer

Article References: Lee, J., Lee, J., Tae, I. H., Kang, Y., Kim, J., Ryu, T. Y., Yang, H., Lee, S.-G., Park, K., Park, D.-S., Jung, C.-R., Lim, J. H., Lee, M.-S., Kim, D.-S., Son, M.-Y., & Cho, H.-S. (2026). Gut microbiota modulation of epigenetic target EHMT2: Lacticaseibacillus rhamnosus Fb7-311 regulated renal cell carcinoma apoptosis and metastasis. Experimental & Molecular Medicine, 58(3), 739-754. https://doi.org/10.1038/s12276-026-01659-6

Image Credits: AI Generated

DOI: 10.1038/s12276-026-01659-6

Keywords: EHMT2 modulation by probiotics, EHMT2 role in cancer progression, epigenetic regulation in renal cell carcinoma, epigenetic targets in kidney cancer, gut microbiome influence on epigenetics, gut microbiota and kidney cancer, gut-kidney axis in cancer therapy, Lacticaseibacillus rhamnosus Fb7-311 effects, microbiota-driven cancer modulation, probiotic strains in oncology, probiotic treatment for RCC, renal cell carcinoma novel therapies